Clinical Trial Update: Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of Fb-PMT in patients with recurrent glioblastoma, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Fb-PMT

Snippet

Sponsor: NanoPharmaceuticals LLC | Conditions: Glioma, Malignant | Phase 1 | Status: RECRUITING